A Phase 3 interventional study of smartphone-assisted health coaching and Lifestyle counseling in Systolic Hypertension, sponsored by York University. Status unknown at 1 site in Canada. Open to participants aged 25 Years to 70 Years. Per ClinicalTrials.gov, last updated 2014-01-10.
Sponsored by York University · Phase 3, Interventional, and Treatment
Patients who receive smartphone-assisted health coaching will have a significantly lower 24 hour ambulatory blood pressure mean than patients who receive just health coaching
Primary Outcome Measure: Mean 24 hour ambulatory blood pressure
Secondary Outcome Measures: Profile of Mood States-SF Vigor Scale; Satisfaction with Life Scale; Positive and Negative Affect Schedule; Hospital Anxiety and Depression Scale; SF - 12
6,689 studies on the registry are indexed under Hypertension; 965 are open to participants now.
This study's planned enrollment of 65 is below the median of 90 across 4,995 interventional studies indexed under Hypertension.
Browse Hypertension studies →York University is the lead sponsor of 51 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
6 months of smartphone assisted lifestyle coaching
Behavioral: smartphone-assisted health coaching
6 months of lifestyle health coaching
Behavioral: Lifestyle counseling
smartphone with software provides self monitoring of exercise, diet and stress reduction; provision of timely reminders; photo-journaling of meals; secure text messaging
Lifestyle counseling
24 hour ambulatory blood pressure mean
24 hour ambulatory blood pressure assessed at baseline and 6 months follow up in experimental and control groups
Time frame: 6 months follow up from baseline
Quality of life self report measures
Profile of Mood States - SF Vigor Scale Satisfaction with Life Scale Positive and Negative Affect Schedule Hospital Anxiety and Depression Scale; SF 12
Time frame: Baseline and 6 months followup
This study is status unknown, as verified in Jan 2014. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
York University